PF-06835919
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PF-06835919, covering 2022-07-21 to 2024-02-16. Get the full timeline:
Most recent: Clinical Trial Update: A STUDY TO COMPARE THE PHARMACOKINETICS OF PF-06835919 IN PARTICIPANTS WITH AND WITHOUT HEPATIC IMPAIRMENT [Phase 1]